| |
 |
|
| |
Ortho-Clinical Diagnostics has pioneered some of the most important technological advances in diagnostics. From early work with blood-type development to the latest advances in automation development, we have long provided the medical community and patients with the
means to make informed medical decisions and enhance patient care.
OCD believes that only by nurturing a working atmosphere that encourages innovation by continuously
providing the right opportunity and support to the team, will the pioneering nature of the division be maintained.
The perfect acknowledgement of the effectiveness of this approach,
has been receiving the
J&J IM Award For Developing Innovative Service Management
Software.
Some of the pioneering work done by Ortho-Clinical Diagnostics that has revolutionized the diagnostic industry are:
- The introduction of the first Anti-D reagent for
Rh typing.
- Launch of the RhoGAM – the first Anti-D immunoglobulin
injection for preventing the haemolytic disease of the
new born
- The “Column Agglutination Technology” or CAT, which
automates blood grouping, typing and antibody cross match.
- The patented thin-film MicroSlide technology for
biochemical estimations on the Vitros chemistry systems that
eliminates the use of water & eradicates manual errors
while delivering better patient outcomes.
- The patented Enhanced Chemiluminescence Technology for
immunoassay testing on the Vitros ECi platform that increases
the sensitivity and specificity of the assays.
- The Ortho-Chiron co-development of the first HCV antibody
test for blood screening which made the world blood supply
safer by leaps & bounds.
- The introduction of an HCV Antigen assay on the
ELISA format that reduces the window period of HCV infection
substantially and helps make the transfusions safer.
|
|
| |
|
|
| |
|
|
 |
 |
 |
|
 |
J&J has always believed
that its strength lies within the talent it attracts
and retains. The Management strive to create a great
work environment to help employees reach their potential.
|
|
| |
|
|
|
|
|
|
|
|
